Moshina, Nataliia
Gräwingholt, Axel
Lång, Kristina
Mann, Ritse
Hovda, Tone
Hoff, Solveig Roth
Skaane, Per
Lee, Christoph I.
Aase, Hildegunn S.
Aslaksen, Aslak B.
Hofvind, Solveig http://orcid.org/0000-0003-0178-8939
Funding for this research was provided by:
Kreftforeningen (no number)
UiT The Arctic University of Norway
Article History
Received: 7 September 2023
Accepted: 21 December 2023
First Online: 8 February 2024
Declarations
:
: The study was approved by the Regional Committee for Medical and Health Research Ethics in Norway (no. 2015/424 and 13294). Permission to use data collected before and after the To-Be studies was provided by the Cancer Registry Regulation §1–9, which gives the Cancer Registry the legal right to collect and analyze personal health information from participants in BreastScreen Norway. Written informed consent was not required for this study because we used de-identified data from women who did not refuse the Cancer Registry of Norway to use their data for quality assurance and research.
: Not applicable.
: Ritse Mann is a member of the Insights into Imaging Advisory Editorial Board. He has not taken part in the review or selection process of this article. Solveig Hofvind is the head of BreastScreen Norway but has an independent fixed position at the Cancer Registry of Norway. The remaining authors declare that they have no competing interests.